Luseogliflozin increases beta cell proliferation through humoral factors that activate an insulin receptor- and IGF-1 receptor-independent pathway
Jun Shirakawa, Kazuki Tajima, Tomoko Okuyama, Mayu Kyohara, Yu Togashi, Dario F. De Jesus, Giorgio Basile, Tatsuya Kin, A. M. James Shapiro, Rohit Kulkarni, Yasuo Terauchi
Topics & Concepts
Internal medicineEndocrinologyBeta cellInsulin receptorInsulinStreptozotocinMedicineIsletInsulin resistanceDiabetes mellitusPancreatic function and diabetesDiabetes Treatment and ManagementDiabetes and associated disorders